Sunitinib Imatinib
Showing 1 - 25 of 1,082
Gastrointestinal Stromal Tumors Trial in Changsha (Apatinib Mesylate, Sunitinib, Imatinib dosage, Dasatinib, Reveratinib)
Recruiting
- Gastrointestinal Stromal Tumors
- Apatinib Mesylate
- Sunitinib, Imatinib dosage, Dasatinib, Reveratinib
-
Changsha, Hunan, ChinaXiangya Hospital, Central South University
Mar 1, 2023
Gastrointestinal Stromal Tumors Trial in Seoul (Paclitaxel)
Recruiting
- Gastrointestinal Stromal Tumors
-
Seoul, Korea, Republic ofAsan Medical Center
Dec 30, 2022
Gastrointestinal Stromal Tumors Trial in Tokyo (Pimitespib, Imatinib, Sunitinib)
Recruiting
- Gastrointestinal Stromal Tumors
- Pimitespib
- +2 more
-
Tokyo, JapanA site selected by Taiho Pharmaceutical Co., Ltd.
Aug 4, 2022
Gastrointestinal Stromal Tumors Trial in Seoul (Rivoceranib Mesylate, Paclitaxel)
Not yet recruiting
- Gastrointestinal Stromal Tumors
- Rivoceranib Mesylate, Paclitaxel
-
Seoul, Korea, Republic ofAsan Medical Center, University of Ulsan College of Medicine
Jun 7, 2023
Gastrointestinal Stromal Tumor, Malignant Trial in Changsha (Entacapone, Imatinib Mesylate)
Active, not recruiting
- Gastrointestinal Stromal Tumor, Malignant
- Entacapone
- Imatinib Mesylate
-
Changsha, Hunan, ChinaBin Li, MD
Nov 24, 2021
Gastrointestinal Stromal Tumors Trial in Seoul (PDR001, Imatinib)
Recruiting
- Gastrointestinal Stromal Tumors
- PDR001, Imatinib
-
Seoul, Korea, Republic ofAsan Medical Center
Jun 22, 2021
Avapritinib in Chinese Gastrointestinal Stromal Tumor in Real
Recruiting
- Gastrointestinal Stromal Tumors
- Avapritinib
- Tyrosine kinase inhibitors other than avapritinib ( imatinib, sunitinib, et al )
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Sep 14, 2022
Gastro Intestinal Stromal Tumour Trial in France (Lenvatinib, Placebo, Best supportive care)
Recruiting
- Gastro Intestinal Stromal Tumour
- Lenvatinib
- +2 more
-
Marseille, Bouches Du Rhône, France
- +7 more
Jul 28, 2021
Gastrointestinal Stromal Tumors Trial in Beijing (Famitinib capsules, Sunitinib Capsules)
Recruiting
- Gastrointestinal Stromal Tumors
- Famitinib capsules
- Sunitinib Capsules
-
Beijing, China307 Hospital of PLA
Nov 30, 2020
Advanced Gastrointestinal Stromal Tumors Trial in France (PD 0332991)
Completed
- Advanced Gastrointestinal Stromal Tumors
- PD 0332991
-
Bordeaux, Gironde, France
- +8 more
Dec 30, 2020
Metastatic Gastrointestinal Stromal Tumor Trial in Worldwide (cabozantinib)
Completed
- Metastatic Gastrointestinal Stromal Tumor
-
Leuven, Belgium
- +10 more
Jul 14, 2021
3rd Line GIST Trial in Worldwide (ST571 + BYL719)
Completed
- 3rd Line GIST
- ST571 + BYL719
-
Portland, Oregon
- +10 more
Dec 17, 2020
Gastrointestinal Stromal Tumor(GIST) Trial in China (Ripretinib, Sunitinib)
Recruiting
- Gastrointestinal Stromal Tumor(GIST)
-
Beijing, Beijing, China
- +17 more
Dec 17, 2020
Gastrointestinal Stromal Tumor Trial in Boston, Portland, Philadelphia (regorafenib)
Completed
- Gastrointestinal Stromal Tumor
-
Boston, Massachusetts
- +3 more
Aug 7, 2020
Unresectable Gastrointestinal Stromal Tumor (GIST), Locally Advanced Gastrointestinal Stromal Tumor (GIST), Metastatic
Recruiting
- Unresectable Gastrointestinal Stromal Tumor (GIST)
- +2 more
- Atezolizumab 1200 mg
- Imatinib 400 MG
-
Lyon, Rhône, France
- +4 more
Apr 28, 2022
Gastrointestinal Stromal Tumors Trial in Seoul (Paclitaxel)
Completed
- Gastrointestinal Stromal Tumors
-
Seoul, Korea, Republic ofAsan Medical Center, University of Ulsan College of Medicine
Jan 6, 2020
Gastrointestinal Stromal Tumors Trial in Seoul (Imatinib, Placebo)
Completed
- Gastrointestinal Stromal Tumors
- Imatinib
- Placebo
-
Seoul, Songpa-gu, Korea, Republic ofAsan Medical Center
Jan 6, 2020
Gastrointestinal Stromal Tumors Trial in Seoul, (dovitinib)
Completed
- Gastrointestinal Stromal Tumors
-
Seoul,, Korea, Republic ofAsan Medical Center, University of Ulsan College of Medicine
Jan 6, 2020
Second-line Pharmacotherapy Patterns and Outcomes of Advanced
Not yet recruiting
- Gastrointestinal Stromal Tumors
-
Guangzhou, Guangdong, ChinaThe first affiliated hospital,Sun yat-sen university
Jun 30, 2022
Gastrointestinal Stromal Tumors (GISTs) Trial in Seoul (Regorafenib)
Completed
- Gastrointestinal Stromal Tumors (GISTs)
-
Seoul, Korea, Republic ofAsan Medical Center, University of Ulsan College of Medicine
Jan 6, 2020